Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 ...

Health officials have advised people to get the updated COVID-19 vaccine ahead of the holidays — at least two weeks before.

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

NEW YORK, October 29, 2024--Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2024 and raised its full ... (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vacci ...

"I don’t want to have a heart attack" by taking any more jabs, relatively young agency branch chief tells undercover date.

Moderna has secured FDA approval for its respiratory ... effect seen with both GSK and Pfizer’s products. There’s still one more step before Moderna’s vaccine can take on Arexvy and Abrysvo ...

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

To potentially include adolescents and antibody persistence up to two years ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq ... You may report side effects to the FDA at 1-800-FDA-1088. The full ...

Kennedy Jr., Nesheiwat doesn’t have a history of criticizing vaccines. The FDA has approved Attruby ... undercuts existing ATTR-CM drugs made by Pfizer. Vutisiran, an RNA-silencing therapy ...

Makary, a Johns Hopkins University surgeon, is known for being critical of the current medical establishment. He is also an executive of the telehealth company Sesame, linking patients to providers of ...